Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Schwenk, Robert ^a   Banania, Glenna ^b   Epstein, Judy ^b   Kim, Yohan ^d   Peters, Bjoern ^d   Belmonte, Maria ^b   Ganeshan, Harini ^b   Huang, Jun ^b   Reyes, Sharina ^b   Stryhn, Anette ^c   Ockenhouse, Christian F ^a   Buus, Soren ^c   Richie, Thomas L ^b   Sedegah, Martha ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Activation markers; CD8+ T cells; Malaria; MHC I tetramers

Indexed keywords

ADENOVIRUS VECTOR; APICAL MEMBRANE ANTIGEN 1; CD38 ANTIGEN; CD8 ANTIGEN; FLUOROCHROME; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MALARIA VACCINE;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL LABELING; CELL SURFACE; CONTROLLED STUDY; DISEASE MARKER; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALARIA; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLASMODIUM FALCIPARUM; RESEARCH SUBJECT; STAINING;

ANTIGENS, CD38; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; HEALTHY VOLUNTEERS; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PROTOZOAN PROTEINS; STAINING AND LABELING; T-LYMPHOCYTE SUBSETS; VACCINES, SYNTHETIC;

EID: 84886388079     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-376     Document Type: Article

References (16)

1. Protective immunity induced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nussenzweig R, Vanderberg J, Most H, Orton C, Nature 1967 261 160 162
2. Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Gwadz R, Cochrane A, Nussenzweig V, Nussenzweig R, Bull World Health Organ 1979 57 Suppl 1 165 173 120766 (Pubitemid 10110809)
3. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. Hoffman S, Goh L, Luke T, Schneider I, Le T, Doolan D, Sacci J, de la Vega P, Dowler M, Paul C, Gordon D, Stoute J, Church L, Sedegah M, Heppner D, Ballou W, Richie T, J Infect Dis 2002 185 1155 1164 10.1086/339409 11930326 (Pubitemid 34297774)
4. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Weiss W, Sedegah M, Beaudoin R, Miller L, Good M, Proc Natl Acad Sci USA 1988 85 573 576 10.1073/pnas.85.2.573 2963334 (Pubitemid 18059317)
5. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. Weiss W, Jiang C, PLoS One 2012 7 31247 10.1371/journal.pone. 0031247 22355349
6. DNA prime/Adenovirus boost malaria vaccine encoding P. Falciparum CSP and AMA1 induces sterile protection associated with cell-Mediated immunity. Chuang I, Sedegah M, Cicatelli S, Spring M, Polhemus M, Tamminga C, Patterson N, Guerrero M, Bennett JW, McGrath S, Ganeshan H, Belmonte M, Farooq F, Abot E, Banania JG, Huang J, Newcomer R, Rein L, Litilit D, Richie NO, Wood C, Murphy J, Sauerwein R, Hermsen CC, McCoy AJ, Kamau E, Cummings J, Komisar J, Sutamihardja A, Shi M, Epstein JE, Maiolatesi S, Tosh D, Limbach K, Angov E, Bergmann-Leitner E, Bruder JT, Doolan DL, King CR, Carucci D, Dutta S, Soisson L, Diggs C, Hollingdale MR, Ockenhouse CF, Richie TL, et al. PLoS One 2013 8 55571 10.1371/journal.pone.0055571 23457473
7. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins W, Nussenzweig R, Nussenzweig V, Science 1986 232 881 884 10.1126/science.3085218 3085218 (Pubitemid 16117400)
8. Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. Depinay N, Franetich J, Grüner A, Mauduit M, Chavatte J, Luty A, Van Gemert G, Sauerwein R, Siksik J, Hannoun L, Mazier D, Snounou G, Rénia L, PLoS One 2011 6 17464 10.1371/journal.pone.0017464 21394207
9. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Miller J, van der Most R, Akondy R, Glidewell J, Albott S, Masopust D, Murali-Krishna K, Mahar P, Edupuganti S, Lalor S, Germon S, Del Rio C, Mulligan M, Staprans S, Altman J, Feinberg M, Ahmed R, Immunity 2008 28 710 722 10.1016/j.immuni.2008.02.020 18468462
10. Adenovirus 5-Vectored P. Falciparum vaccine expressing CSP and AMA1: Part A: Safety and immunogenicity in seronegative adults. Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, Abot E, Banania G, Sayo R, Farooq F, Belmonte M, Manohar N, Richie NO, Wood C, Long CA, Regis D, Williams F, Shi M, Chuang I, Spring M, Epstein J, Mendoza-Silveiras J, Limbach K, Patterson N, Bruder J, Doolan D, King C, Soisson L, Diggs C, Carucci D, Dutta S, Hollingdale M, Ockenhouse C, Richie T, et al. PLoS One 2011 6 24586 10.1371/journal.pone. 0024586 22003383
11. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1: Part B: safety, immunogenicity and protective efficacy of the CSP component. Tamminga C, Sedegah M, Regis D, Chuang I, Epstein J, Spring M, Mendoza-Silveiras J, McGrath S, Maiolatesi S, Reyes S, Steinbeiss V, Fedders C, Smith K, House B, Ganeshan H, Lejano J, Abot E, Banania G, Sayo R, Farooq F, Belmonte M, Murphy J, Komisar J, Williams J, Shi M, Brambilla D, Manohar N, Richie N, Wood C, Limbach K, Patterson N, Bruder J, Doolan D, King C, Diggs C, Soisson L, Carucci D, Levine G, Dutta S, Hollingdale M, Ockenhouse C, Richie T, et al. PLoS One 2011 6 25868 10.1371/journal.pone.0025868 22003411
12. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein. Sedegah M, Kim Y, Peters B, McGrath S, Ganeshan H, Lejano J, Abot E, Banania G, Belmonte M, Sayo R, Farooq F, Doolan DL, Regis D, Tamminga C, Chuang I, Bruder JT, King CR, Ockenhouse CF, Faber B, Remarque E, Hollingdale MR, Richie TL, Sette A, Malar J 2010 9 241 257 10.1186/1475-2875-9-241 20735847
13. One pot mix-and-read peptide-MHC tetramers. Leisner C, Loeth N, Lamberth K, Justesen S, Sylvester-Hvid C, Schmidt E, Claesson M, Buus S, Stryhn A, PLoS One 2008 3 167813
14. NetMHCpan, a method for MHC class I binding prediction beyond humans. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M, Immunogenetics 2009 61 1 13 10.1007/s00251-008-0341-z 19002680
15. Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. Alanio C, Lemaitre F, Law H, Hasan M, Albert M, Blood 2010 115 3718 3725 10.1182/blood-2009-10-251124 20200354
16. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Querec T, Akondy R, Lee E, Cao W, Nakaya H, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, Vencio RZ, Mulligan M, Aderem A, Ahmed R, Pulendran B, Nat Immunol 2009 10 116 125 19029902